Search

Home > The Bio Report > Cell Therapies that Can Do a Solid for People with Cancer
Podcast: The Bio Report
Episode:

Cell Therapies that Can Do a Solid for People with Cancer

Category: Business
Duration: 00:51:49
Publish Date: 2024-10-23 07:00:00
Description:

In August, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra, the first engineered cell therapy to treat a solid tumor. The T cell receptor gene therapy is approved to treat synovial sarcoma, a rare soft tissue cancer that most often affects young adults. We spoke to Adrian Rawcliffe, CEO of Adaptimmune, about the approval, how TCR therapies differ from CAR T therapies, and what other cancers might benefit from such an approach.  

Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes